CompanyGraph
Guardian Pharmacy Services Inc.
GRDN · NYSE Arca · United States
guardianpharmacy.comFinancials as of FY2025
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $2.57B, above the global median of $1.15B
- PositionPrice-to-book is 11.62×, higher than 95% of its Medical Care Facilities peers (median 2.44×)
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.57BUSDvs all stocks (USD)
Trailing P/E
48.24xvs Medical Care Facilities peers
Revenue (TTM)
1.46BUSDvs all stocks (USD)
Profit Margin
3.65%vs Medical Care Facilities peers
52-Week Change
93.97%vs all stocks
Market Capitalization
2.57BUSDvs all stocks (USD)
Enterprise Value
2.55BUSDvs all stocks (USD)
Trailing P/E
48.24xvs Medical Care Facilities peers
Forward P/E
29.83xvs Medical Care Facilities peers
PEG Ratio
1.21xvs Medical Care Facilities peers
Price to Sales (TTM)
1.76xvs Medical Care Facilities peers
Price to Book (MRQ)
11.62xvs Medical Care Facilities peers
Enterprise to Revenue
1.75xvs Medical Care Facilities peers
Enterprise to EBITDA
23.02xvs Medical Care Facilities peers
Gross Margin
22.67%vs Medical Care Facilities peers
Profit Margin
3.65%vs Medical Care Facilities peers
Operating Margin
6.20%vs Medical Care Facilities peers
Return on Assets (TTM)
14.43%vs Medical Care Facilities peers
Return on Equity (TTM)
26.91%vs Medical Care Facilities peers
Revenue (TTM)
1.46BUSDvs all stocks (USD)
Revenue per Share (TTM)
23.22USDUpdated Jul 19, 2026Quarterly Revenue Growth
2.20%vs Medical Care Facilities peers
Gross Profit (TTM)
304.68MUSDvs all stocks (USD)
EBITDA (TTM)
102.30MUSDvs all stocks (USD)
Net Income (TTM)
53.07MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
40.70%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
88.77MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
66.99MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Care Facilities peers
Minority Interest (Equity)
12.16MUSDFY2025 · Dec 31, 2025Revenue
1.45BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.16BUSDFY2025 · Dec 31, 2025Gross Profit
292.72MUSDFY2025 · Dec 31, 2025Operating Income
72.70MUSDvs all stocks (USD)
Pre-tax Income
73.42MUSDFY2025 · Dec 31, 2025Income Tax Expense
24.46MUSDFY2025 · Dec 31, 2025Net Income
48.96MUSDFY2025 · Dec 31, 2025EBIT
74.09MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
96.42MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
220.02MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
665.00KUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
48.96MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
261.00KUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00USDFY2025 · Dec 31, 2025Operating Cash Flow
95.06MUSDFY2025 · Dec 31, 2025Free Cash Flow
75.51MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
65.62MUSDFY2025 · Dec 31, 2025Income Tax Paid
21.54MUSDFY2025 · Dec 31, 2025Interest Paid
650.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
48.96MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
22.34MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
3.07MUSDFY2025 · Dec 31, 2025Stock-based Compensation
13.85MUSDFY2025 · Dec 31, 2025Other Non-cash Items
1.07MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-8.55MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
16.40MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-2.08MUSDFY2025 · Dec 31, 2025Capital Expenditures
-19.55MUSDFY2025 · Dec 31, 2025Net Acquisitions
-13.42MUSDFY2025 · Dec 31, 2025Other Investing Activity
736.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-32.23MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-4.98MUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Common Stock Repurchase
-29.04MUSDFY2025 · Dec 31, 2025Common Dividends Paid
0.00USDFY2025 · Dec 31, 2025Other Financing Charges
-2.09MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-7.07MUSDFY2025 · Dec 31, 2025Shares Outstanding
63.32MSharesUpdated Jul 19, 2026Float Shares
31.99MSharesUpdated Jul 19, 2026Shares Short
3.09MSharesUpdated Jul 19, 2026Short Ratio
6.49daysvs all stocks
Short % of Shares Outstanding
8.33%vs all stocks
% Held by Insiders
37.52%vs all stocks
% Held by Institutions
59.13%vs all stocks
Total Cash (MRQ)
64.89MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.02USDUpdated Jul 19, 2026Total Debt (MRQ)
41.19MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.1772xvs Medical Care Facilities peers
Current Ratio (MRQ)
1.47xvs Medical Care Facilities peers
Book Value per Share (MRQ)
3.49USDUpdated Jul 19, 2026Total Assets
412.66MUSDvs all stocks (USD)
Total Current Assets
221.63MUSDFY2025 · Dec 31, 2025Total Liabilities
194.73MUSDFY2025 · Dec 31, 2025Total Non-current Assets
191.02MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
34.03MUSDFY2025 · Dec 31, 2025Total Current Liabilities
160.70MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
65.62MUSDFY2025 · Dec 31, 2025Accounts Receivable
101.61MUSDFY2025 · Dec 31, 2025Inventory
43.36MUSDFY2025 · Dec 31, 2025Accounts Payable
116.21MUSDFY2025 · Dec 31, 2025Short-term Debt
7.15MUSDFY2025 · Dec 31, 2025Other Current Liabilities
22.30MUSDFY2025 · Dec 31, 2025Long-term Debt
29.99MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
4.04MUSDFY2025 · Dec 31, 2025Common Stock (Book)
63.00KUSDFY2025 · Dec 31, 2025Retained Earnings
66.34MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
217.92MUSDvs all stocks (USD)
52-Week Low
19.30USDUpdated Jul 19, 202652-Week High
44.00USDUpdated Jul 19, 202652-Week Change
93.97%vs all stocks
50-Day MA
39.63USDUpdated Jul 19, 2026200-Day MA
33.60USDUpdated Jul 19, 2026Avg 10-Day Volume
314.55KSharesUpdated Jul 19, 2026Avg 30-Day Volume
440.90KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
0.8400USDUpdated Jul 19, 2026Other Income / Expense
1.39MUSDFY2025 · Dec 31, 20255 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Three Asset-Base Ratios Elevated
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Low Fixed-Asset Share With Elevated Turnover
It owns few buildings and machines, yet gets more sales and profit from its assets than its industry does.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 11.62×, higher than 95% of its Medical Care Facilities peers (median 2.44×)Significant
Price-to-book: 11.62Industry median: 2.44Industry P95: 11.58Peers compared: 70.00
Financial Health
Altman Z-Score 12.41: safe zoneNotable
Altman Z-Score: 12.41
High earnings qualityNotable
Earnings Quality Score: 1.14
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $2.57B, above the global median of $1.15BNotable
Market cap (USD): 2,565,752,089Global Median: 1,146,734,693.424
Revenue is $1.46B, above the global median of $520.53MNotable
Revenue (USD): 1,455,971,968Global Median: 520,528,949.311
Levered free cash flow is $66.99M, above the global median of $16.24MNotable
Levered free cash flow (USD): 66,986,752Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Spark New Zealand Limited
Tier 1FlowThroughput-Bound ConversionRuleProduction
Jiayou International Logistics Co., Ltd.
Tier 1FlowThroughput-Bound ConversionInterfaceRisk
Dnow Inc.
Tier 1FlowThroughput-Bound ConversionInterfaceRisk
Sinch AB
Tier 1FlowThroughput-Bound ConversionRuleInterface
Macnica Holdings Inc.
Tier 1FlowThroughput-Bound ConversionRiskInterface
DXP Enterprises, Inc.
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
Pitney Bowes Inc.
Tier 1FlowThroughput-Bound ConversionInterfaceRisk
Xiamen Xiangyu Co., Ltd.
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
Liaoning Chengda Co., Ltd.
Tier 1FlowThroughput-Bound ConversionRiskInterface
Runjian Co., Ltd.
Tier 1FlowThroughput-Bound ConversionRuleProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
A1 Capital Yatirim Menkul Değerler A.Ş.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedReceivables Heavy and GrowingLow Fixed-Asset Share With Elevated TurnoverThree Asset-Base Ratios Elevated
Ies Holdings Inc.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedReceivables Heavy and GrowingLow Fixed-Asset Share With Elevated TurnoverThree Asset-Base Ratios Elevated
Oil-Dri Corporation of America
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedReceivables Heavy and GrowingLow Fixed-Asset Share With Elevated TurnoverThree Asset-Base Ratios Elevated